The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Riabina M.V.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Chesnokova N.B.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Okhotsimskaia T.D.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

Kuznetsova T.P.

FGBU Moskovskiĭ nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ im. Gel'mgol'tsa Minzdrava RF, Moskva

The pathogenetic substantiation of the use of angiotensin-converting enzyme for the treatment of diabetic retinopathy

Authors:

Riabina M.V., Chesnokova N.B., Okhotsimskaia T.D., Kuznetsova T.P.

More about the authors

Journal: Problems of Endocrinology. 2012;58(5): 37‑40

Views: 772

Downloaded: 11


To cite this article:

Riabina MV, Chesnokova NB, Okhotsimskaia TD, Kuznetsova TP. The pathogenetic substantiation of the use of angiotensin-converting enzyme for the treatment of diabetic retinopathy. Problems of Endocrinology. 2012;58(5):37‑40. (In Russ.)

Recommended articles:
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.